Impact of a Mobile Phone and Educational Intervention
Launched by KENT STATE UNIVERSITY · Mar 12, 2025
Trial Information
Current as of April 30, 2025
Completed
Keywords
ClinConnect Summary
This pilot study evaluated the feasibility and impact of a combined intervention on HRQOL and three health behaviors (nutrition, physical activity, avoiding triggers) in African Americans with asthma or COPD. This was a community-based intervention that recruited participants from six predominantly African American churches. African Americans over 18 years with asthma or COPD were randomized to control or intervention. Intervention received education (asthma COPD (ACOPD) Program) and a one-month text-messaging program, while control received the ACOPD Program alone. Measures were made at th...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Eligible participants for the study were African American adults of 18 years and above.
- • Participants had to have reported physician diagnosed (on the survey distributed at the church) or spirometry diagnosed (at the community health fair) asthma or COPD, access to a text-messaging enabled mobile phone, and provision of signed informed consent.
- Exclusion Criteria:
- • Individuals unwilling to participate in the study and patients with other chronic lung diseases, terminal, or comorbid illnesses more severe in nature than asthma or COPD (i.e., heart disease and cancer) were excluded from the study.
About Kent State University
Kent State University is a distinguished public research institution located in Kent, Ohio, renowned for its commitment to academic excellence and innovation in various fields, including health sciences. As a clinical trial sponsor, the university leverages its extensive resources, expertise, and collaborative networks to advance medical research and improve patient outcomes. Kent State University prioritizes ethical standards and regulatory compliance in its clinical trials, fostering a rigorous environment for the development of new therapies and interventions. Through its dedication to research and community engagement, the university aims to contribute significantly to the advancement of healthcare knowledge and practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kent, Ohio, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported